These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 512844)

  • 21. Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications.
    Yeleswaram K; McLaughlin LG; Knipe JO; Schabdach D
    J Pineal Res; 1997 Jan; 22(1):45-51. PubMed ID: 9062870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
    Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
    Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
    J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of codeine-resinate and chlorpheniramine-resinate sustained-release suspension and its pharmacokinetic evaluation in beagle dogs.
    Zeng HX; Cheng G; Pan WS; Zhong GP; Huang M
    Drug Dev Ind Pharm; 2007 Jun; 33(6):649-65. PubMed ID: 17613029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prazosin first-pass metabolism and hepatic extraction in the dog.
    Rubin P; Yee YG; Anderson M; Blaschke T
    J Cardiovasc Pharmacol; 1979; 1(6):641-7. PubMed ID: 94630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects.
    Holazo AA; Colburn WA; Gustafson JH; Young RL; Parsonnet M
    J Pharm Sci; 1984 Aug; 73(8):1108-13. PubMed ID: 6491914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-pass metabolism of nomifensine in dogs.
    Lindberg R; Sellman R; Iisalo E
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):21-5. PubMed ID: 4029216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and bioavailability of 2-mercaptopropionylglycine administered intravenously and orally in dogs.
    Hoppe A; Denneberg T; Emanuelsson BM; Kågedal B; Lindgren S
    J Vet Pharmacol Ther; 1991 Dec; 14(4):374-84. PubMed ID: 1774814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man.
    Dawson M; Braithwaite PA; Roberts MS; Watson TR
    Br J Clin Pharmacol; 1985 Jan; 19(1):79-86. PubMed ID: 3978023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-dose pharmacokinetics of metoclopramide.
    Ross-Lee LM; Eadie MJ; Hooper WD; Bochner F
    Eur J Clin Pharmacol; 1981; 20(6):465-71. PubMed ID: 7286058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of propranolol in the dog.
    Tse FL; Sanders TM; Reo JP
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of diazepam in the dog.
    Löscher W; Frey HH
    Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):180-95. PubMed ID: 7337498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and bioavailability of etintidine in beagle dogs: effects of routes of administration, doses, dosage forms, and chronic dosing.
    Huang SM; Abrams LS; Marriott TB; Weintraub HS
    Biopharm Drug Dispos; 1988; 9(1):71-83. PubMed ID: 3342286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability and first-pass metabolism of oral pentazocine in man.
    Ehrnebo M; Boréus LO; Lönroth U
    Clin Pharmacol Ther; 1977 Dec; 22(6):888-92. PubMed ID: 923183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meperidine pharmacokinetics following intravenous, peroral and buccal administration in beagle dogs.
    Ritschel WA; Neub M; Denson DD
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):811-5. PubMed ID: 3441166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.